Clinical trial
A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed…
NCT00350545 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00350545 |
|---|---|
| Title | A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease |
| Official title | A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Drug |
| Interventions | Rituximab, Prednisone, Cyclosporine A, tacrolimus |
| Enrollment | 37 |
| Start date | Aug 1, 2006 |
| Primary completion | May 1, 2012 |
| Completion | Oct 1, 2014 |
| First posted | Jul 10, 2006 |
| Last update posted | Nov 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: